Dr. Gordon Corbett Keith Dow

Infection Prevention and Control Director, The Moncton Hospital, Horizon Health Network / Regional Infectious Diseases Medical Director, Horizon Health Network

BSc, MSc, MD, FRCPC

Gordon Dow is an Infectious Disease consultant in full-time clinical practice at Horizon’s The Moncton Hospital in New Brunswick and is an Assistant Professor of Medicine at Dalhousie University. He obtained his medical degree from Dalhousie University in 1987 and subsequently obtained specialist certification in Internal Medicine after completing an Internal Medicine residency at the University of British Columbia in 1992. He then obtained a subspecialty certification in Infectious Diseases in 1993 at the University of Manitoba, and then completed a two-year research fellowship at the University of Manitoba and obtained a Masters in Community Health Sciences in 1999.

He currently is:

  • Division Head of Infectious Diseases at Horizon’s The Moncton Hospital
  • Director of the Moncton Hospital HIV Treatment Program
  • Chair of the Regional Infection Prevention and Control Committee
  • Co-chairman for the Horizon Health Network Regional COVID-19 Infection Prevention and Control Committee
  • Horizon’s Regional Infectious Diseases Medical Director
  • Member of the Provincial Pandemic Task Force
  • Director of the Diabetes Foot Clinics at The Moncton Hospital and Horizon’s Miramichi Regional Hospital

He has participated in over 30 clinical trials. Research interests include the management of bone, joint and soft tissue infection, amputation prevention in persons with diabetes, HIV infection, and management of infection in immunocompromised hosts. Pandemic response planning has been his major focus since the spring of 2020.

Gord and his wife, Lynn, have 3 adult children, Natalie (John), Mareika (Jesse) and Caleb (Meghan) and one granddaughter, Ada. In his free time, Gord enjoys exploring our incredible Canadian outdoors, canoeing the historic New Brunswick waterways utilized by First Nations and woodworking. Going forward, he hopes to be able to devote more time toward nature conservancy in New Brunswick.

  • BSc, Biology, University of New Brunswick, 1983
  • MD cum laude with Distinction, Dalhousie University, 1987
  • Internal Medicine Residency University of British Columbia, 1988-91
  • FRCP(C) Internal Medicine, 1992
  • Infectious Disease Fellowship University of Manitoba, 1991-93
  • FRCP(C) Infectious Disease, 1993
  • Masters in Community Health Sciences, University of Manitoba, 1999

  • Assistant Professor, Faculty of Medicine, Dalhousie University
  • Clinical Assistant Professor, Department of Medicine, Memorial University
  • Infectious Diseases, Division Head, The Moncton Hospital
  • HIV Director, The Moncton Hospital
  • Diabetes Foot Program, Director, The Moncton Hospital and Miramichi Regional Hospital
  • Infection Prevention and Control, Director, The Moncton Hospital
  • Regional Infection Prevention and Control Committee, Chair, Horizon Health Network
  • Regional COVID-19 Infection Prevention and Control Committee, Co-Chair, Horizon Health Network
  • Infectious Diseases, Regional Director, Horizon Health Network
  • Co-chair of Horizon Infectious Diseases/Medical Microbiology Advisory Group
  • Pandemic Task Force, Province of New Brunswick

  • Dow G, Chow A. Legionella Associated Lung Abscess. Can J Infect Dis 1992;3(6):315-318.
  • Dow G, Reid G, Horsman D, Barnet M. Unusual Rheumatological and Cardiological Manifestations of Acute Myelogenous Leukemia in a Patient with Klinefelters syndrome. Leuk Lymph 1993;9:419-421.
  • Dow G, Ronald A. Skin Tests. In: Infectious Diseases, Hoeprich P, Jordan M, Ronald A, editors. A treatment of infectious processes. 5th Ed. Philadelphia: Lippincott, 1994:194-200.
  • Dow G, Ronald A. Miscellaneous antibacterial drugs. In: Clinical Infectious Diseases, A Practical Approach. Root R, editor. First ed. New York: Oxford University Press, 1999:319-325.
  • Nicolle LE, Unhanova J, Orr P, Kraut A, VanAmeyde K, Dow G. Infectious Diseases on a General Internal Medicine Clinical Teaching Unit. Canadian Journal of Infectious Diseases 1999; 10(1): 33-38.
  • Dow G. Diabetic foot care plan. Canadian Journal of Infectious Disease 2000; 11(Suppl D): 15D-21D.
  • Dow G. Infection in Chronic Wounds. In: Chronic Wound Care: A clinical source book for healthcare professionals. Third Ed. Wayne: HMP Communications, 2001: 343-356.
  • Dow G. Adjunctive measures for the management of the diabetic foot. COA Bulletin 2002; May-June: 26-27.
  • Dow G. Bacterial Swabs and the Chronic Wound: When, How, and What Do They Mean. Ostomy Wound Management, May 2003; (49): issue 5A (suppl): 8-13.
  • Dow G, Rao P, Harding G, Brunka J, Kennedy J, Alfa M, Nicolle LE. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin. Infect. Dis. 2004; 39:658-664.
  • Dignani MC, Rex JH, Chan KW, Dow G, deMagalhaes-Silverman M, Maddox A, Walsh T, Anaissie E. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukaemia. Cancer. 2005 Jul 1; 104(1): 199-204.
  • Kew AK, Macaulay R, Burrell S, Rubin S, Dow G, Couban S. Central nervous system graft-versus-host disease presents with granulomatous encephalitis. Bone Marrow Transplantation. 2007; 40: 183-184.
  • Browne A, Dow G, Sibbald G. Infected wounds: definitions and controversies. In: Falanga V (ed) Cutaneous Wound Healing. London: Martin D unit 2. 2001; pp 203-219.
  • Dow G, Browne A, Sibbald G. Infection in Chronic Wounds: Controversies in diagnosis and treatment. Ostomy Wound Management 1999; 45(8): 23-40.
  • King AS, Castro JG, Dow GCK. Nocardia farcinica lung abscess presenting in the context of advanced HIV infection: Spontaneous resolution in response to highly active antiretroviral therapy alone. Can J Infect Dis Med Microbiol 2009; 20(3): e103-e106.
  • Dow G, Field D, Mancuso M, Allard J. Decolonization of methicillin-resistant Staphylococcus aureus during routine hospital care: Efficacy and long-term follow-up. Can J Infect Dis Med Microbiol 2010; 21(1): 38-44.
  • MacDonald A, Dow G. Ceftobiprole: First reported experience in osteomyelitis. Can J Infect Dis Med Microbiol 2010; 21(3): 138-140.
  • Wong A, Dow G. Hepatosplenic Cat-Scratch Disease as a Cause of Fever of Unknown Origin with Granulomatous Hepatitis. Can J Gen Int Med 2011; 6(3): 83-84.
  • Wuerz T, Hanley M, Shaw R, Close R, Dow G. The impact of a standardized protocol on the quality of wound dressing procedures in hospitalized patients. Can J Infect Cont 2011; 26(3): 175-179.
  • Harris GE, Dupuis L, Mugford G, Johnston L, Haase D, Page G, Haldane H, Harris N, Midodzi WK, Dow G. Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. Can J Infect Dis Med Microbiol 2014; 25(1): e1-e7.
  • Surette A, Ghaly A, Francouer L, Dow G. An Interesting Case of Transcutaneous Aspiration of Myocardial Abscess. JAMMI 2017; 2(1): 75-78.
  • Bader M, Dow G, Yi Y, Howley C, Mugford G, Kelly D. Prevalence and Clinical Characteristics of Gastroesopahageal Reflux Disease in Human Immunodeficiency Virus – Infected Adults. Infect Dis in Clin Practice 2017; 25(1): 29-32.
  • Betsch D, Gao Z, Mugford G, McGrath-Terry, Dow G. Optimizing Glycemic Control in Adults with Type 1 or Type 2 Diabetes Attending a Multidisciplinary Foot Clinic. Can J Diabetes 2018; 42: 437-441.
  • Zhanel GG, Kosar J, Baxter M, Dhami R, Borgia S, Irgan N, MacDonald KS, Dow G, Lagace-Wiens P, Dube M, Bergevin M, Tascini C, Keynan Y, Walkty A, Karlowsky J. Real-life experience with ceftobiprole in Canada: Results from the CLEAR (Canadian Leadership on Antimicrobial Real-life usage) registry. Journal of Global Antimicrobial Resistance 2021; 24: 335-339.

  • Infection Prevention and Control
  • Prevention and Management of Diabetic Foot Infection/Ulceration and Amputation Prevention
  • Bloodstream Infections
  • HIV
  • Management of Bone and Joint Infection
  • Management of Infection in Immunocompromised Hosts
  • Pandemic Planning and Response

  • UBC General Internal Medicine Award for Excellence during Residency training, 1991
  • Golden Jubilee Medal, 2002
  • Northumberland Specialty Teaching Preceptor Award for excellence in teaching, 2006
  • Royal College Prix d’excellence Region 5, 2007
  • Diamond Jubilee Medal, 2012
  • Northumberland Specialty Teaching Preceptor Award for excellence in teaching, 2012/2013